Caspase-independent pathways of programmed cell death: The unraveling of new targets of cancer therapy?

Current Cancer Drug Targets

Volumn 9, Issue 6, 2009, Pages 717-728

  Constantinou, C ^a   Papas, K A ^b   Constantinou, A I ^c  

^a Yasoo Health Ltd   (Cyprus)

^b Yasoo Health   (United States)

^c UNIVERSITY OF CYPRUS   (Cyprus)

Author keywords

AIF; Apoptosis; Caspase independent cell death; Chemotherapy; Programmed cell death

Indexed keywords

2' FLUORO 6,7 METHYLENEDIOXY 2 PHENYL 4 QUINOLONE; 2,4,6 TRIIODOPHENOL; AIF INHIBITOR; ANTINEOPLASTIC AGENT; APOPTOSIS INDUCING FACTOR; APOPTOSIS INHIBITOR; ATIPRIMOD; AZASPIRANE; BENZYLOXYCARBONYLVALYLALANYLASPARTYL FLUOROMETHYL KETONE; BOBEL 24; BZL 101; CALPAIN; CASPASE; CASPASE INHIBITOR; CATHEPSIN; CHM 1; COLECALCIFEROL; CY 103; ESTRADIOL; FLAVONE DERIVATIVE; FLAVOPIRIDOL; HERBACEOUS AGENT; MONOCLONAL ANTIBODY; N METHYLPIPERIDINYL CHLOROPHENYL FLAVONE; PACLITAXEL POLIGLUMEX; PHENOL DERIVATIVE; PROTEIN BAX; PROTEIN BID; QUINOLONE DERIVATIVE; RB 110; RB 49; SERINE PROTEINASE; UNCLASSIFIED DRUG; UNINDEXED DRUG; VITAMIN D;

ADVANCED CANCER; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; BREAST CANCER; CARCINOGENIC ACTIVITY; CARCINOID; CELL DEATH; CELL ORGANELLE; CHROMATIN CONDENSATION; CLINICAL TRIAL; CYTOTOXICITY; DRUG DESIGN; DRUG EFFICACY; DRUG INHIBITION; DRUG MECHANISM; DRUG POTENCY; DRUG TARGETING; GENE EXPRESSION; HUMAN; LEUKEMIA; LIVER CELL CARCINOMA; LUNG NON SMALL CELL CANCER; MEDIATOR; MITOCHONDRION; MOLECULAR INTERACTION; MYELOMA; NEOPLASM; NONHUMAN; OXIDATIVE STRESS; PROSTATE CANCER; PROTEIN INDUCTION; PROTEIN PHOSPHORYLATION; RECEPTOR DOWN REGULATION; RECEPTOR UPREGULATION; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; SOLID TUMOR; TUMOR CELL; TUMOR RESISTANCE;

ANTINEOPLASTIC AGENTS; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; CASPASES; CLINICAL TRIALS AS TOPIC; DRUG DELIVERY SYSTEMS; DRUG DISCOVERY; HUMANS; MITOCHONDRIA; MODELS, BIOLOGICAL; NECROSIS; PEPTIDE HYDROLASES; SIGNAL TRANSDUCTION;

EID: 70349145859     PISSN: 15680096     EISSN: None     Source Type: Journal    
DOI: 10.2174/156800909789271512     Document Type: Review

References (113)

1. Oren, M. Regulation of the p53 tumor suppressor protein. J. Biol. Chem. 1999, 274, 36031-36034. (Pubitemid 30005193)
2. Boujrad, H.; Gubkina, O.; Robert, N.; Krantic, S.; Susin, S. A. AIF-mediated programmed necrosis: A highly regulated way to die. Cell Cycle 2007, 6, 2611-2618.
3. Moretti, L.; Yang, E. S.; Kin, K. W; Lu, B. Autophagy signalling in cancer and its potential as novel target to improve cancer therapy. Drug Res. Updates 2007, 10, 135-143. (Pubitemid 47454724)
4. Festjens, N.; Vanden Berghe, T.; Vandenabeele, P. Necrosis, a well-orchestrated form of cell demise: signalling cascades, important mediators and concominant immune response. Biochim. Biophys. Acta 2006, 1757, 1371-1387.
5. Fombonne, J.; Padron, L.; Enjalbert, A.; Krantic, S.; Torriglia, A. A novel paraptosis pathway involving LEI/L-DNase II for EGF-induced cell death in somato-lactotrope pituitary cells. Apoptosis 2006, 11, 367-375.
6. Melino, G.; Knight, R. A.; Nicotera, P. How many ways to die? How many different models of cell death? Cell Death Differ. 2005, 12, 1457-1462. (Pubitemid 41553978)
7. Okada, H.; Mak, T. W. Pathways of apoptotic and non-apoptotic death in tumor cells. Nat. Rev. Cancer 2004, 4, 592-603. (Pubitemid 39025054)
8. Lorenzo, H. K.; Susin, S. A. Therapeutic potential of AIF-mediated caspase-independent programmed cell death. Drug Resist. Updates 2007, 10, 235-255.
9. Kerr, J. F.; Wyllie, A. H.; Currie, A. R. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br. J. Cancer 1972, 26, 239-257.
10. Kaufmann, S. H.; Hengartner, M. O. Programmed cell death: alive and well in the new millennium. Trends Cell. Biol. 2001, 11, 526-534.
11. Strasser, A.; O'Connor, L.; Dixit, V. M. Apoptosis signalling. Annu. Rev. Biochem. 2000, 69, 217-245.
12. Hirsch, T.; Marchetti, P.; Susin, S. A.; Dallaporta, B.; Zamzami, N.; Marzo, I.; Geuskens, M.; Kroemer, G. The apoptosis-necrosis paradox. Apoptogenic proteases activated after mitochondrial permeability transition determine the mode of cell death. Oncogene 1997, 15, 1573-1581. (Pubitemid 27464650)
13. Degterev, A.; Boyce, M.; Yuan, J. A decade of caspases. Oncogene 2003, 22, 8543-8567.
14. Hengartner, M. O. The biochemistry of apoptosis. Nature 2000, 407, 770-776.
15. Kitanaka, C.; Kuchino, Y. Caspase-independent programmed cell death with necrotic morphology. Cell Death Differ. 1999, 6, 508-515. (Pubitemid 29292106)
16. Leist. M.; Jaatela, M. Four deaths and a funeral: from caspases to alternative mechanisms. Nat. Rev. Mol. Cell Biol. 2001, 2, 589-598.
17. Xiang, J.; Chao, D. T.; Korsmeyer, S. J. BAX-induced cell death may not require interleukin 1 beta-converting enzyme-like proteases. Proc. Natl. Acad. Sci. USA 1996, 93, 14559-14563.
18. Mathiasen, I. S.; Lademann, U.; Jäättelä, M. Apoptosis induced by vitamin D compounds in breast cancer cells is inhibited by Bcl-2 but does not involve known caspases or p53. Cancer Res. 1999, 59, 4848-4856. (Pubitemid 29472887)
19. Maianski, N. A.; Roos, D.; Kuijpers, T. W. Tumor necrosis factor alpha induces a caspase-independent death pathway in human neutrophils. Blood 2003, 101, 1987-1995.
20. Cawles, A.; Janssen, B.; Waeytens, A.; Cuvelier, C.; Brouckaert, P. Caspase inhibition causes hyperacute tumor necrosis factor-induced heat shock via oxidative stress and phospholipase A2. Nat. Immunol. 2003, 4, 387-393. (Pubitemid 36432323)
21. Okuno, S.; Shimizu, S.; Ito, T.; Nomura, M.; Hamada, E.; Tsujimoto, Y.; Matsuda, H. Bcl-2 prevents caspase-independent cell death. J. Biol. Chem. 1998, 273, 34272-34277. (Pubitemid 29008903)
22. Shrivastana, A.; Tiwari, M.; Sinha, R. A.; Kumar, A.; Balapure, A. K.; Bajpai, V. K.; Sharma, R.; Mitra, K.; Tandon, A.; Godbole, M. M. Molecular iodine induces caspase-independent apoptosis in human breast carcinoma cells involving the mitochondria-mediated pathway. J. Biol. Chem. 2006, 281, 19762-19771.
23. Marzo, I.; Perez-Galan, P.; Giraldo, P.; Rubio-Felix, D.; Anel, A.; Naval, J. Cladribine induces apoptosis in human leukaemia cells by caspase-dependent and -independent pathways acting on mitochondria. Biochem. J. 2001, 359, 537-546. (Pubitemid 33063377)
24. Chen, T.; Wong, Y. S. Selenocysteine induces caspase-independent apoptosis in MCF-7 human breast carcinoma cells with involvement of p53 phosphorylation and reactive oxygen species generation. Int. J. Biochem. Cell. Biol. 2009, 41, 666-676.
25. Selvakumar, E.; Hsieh, T. C. Regulation of cell cycle transition and induction of apoptosis in HL-60 leukemia cells by lipoic acid: role in cancer prevention and therapy. J. Hematol. Oncol. 2008, 1, 4.
26. Kim, S. Y.; Park, K. W.; Kim, J. Y.; Jeong, I. Y.; Byun, M. W.; Park, J. E.; Yee, S. T.; Kim, K. H.; Rhim, J. S.; Yamada, K.; Seo, K. I. Thiosulfinates from Allium tuberosum L. induce apoptosis via caspase-dependent and -independent pathways in PC-3 human prostate cancer cells. Bioorg. Med. Chem. Lett. 2008, 18, 199-204.
27. Pozo-uisado, E.; Merino, J. M.; Mulero-Navarro, S.; Lorenzo-Benayas, M. J.; Centeno, F.; Alvarez-Barrientos, A.; Fernandez-Salguero, P. M. Resveratrol-induced apoptosis in MCF-7 human breast cancer cells involves a caspase-independent mechanism with downregulation of Bcl-2 and NF-kappaB. Int. J. Cancer 2005, 116, 1004.
28. Wang, S. W.; Pan, S. L.; Huang, Y. C.; Guh, J. H.; Chiang, P. C.; Huang, D. Y.; Kuo, S. C.; Lee, K. H.; Teng, C. M. CHM-1, a novel synthetic quinolone with potent and selective antimitotic antitumor activity against human hepatocellular carcinoma in vitro and in vivo. Mol. Cancer Ther. 2008, 7, 350-360.
29. Liang, Q.; Li, W.; Zhou, B. Caspase-independent apoptosis in yeast. Biochim. Biophys. Acta 2008, 1783, 1311-1319.
30. Madeo, F.; Carmona-Gutierrez, D.; Ring, J.; Büttner, S.; Eisenberg, T.; Kroemer, G. Caspase-dependent and caspase-independent cell death pathways in yeast. Biochem. Biophys. Res. Commun. 2009, 382, 227-231.
31. Godefroy, N.; Lemaire, C.; Renaud, F.; Rincheval, V.; Perez, S.; Parvu-Ferecatu, I.; Mignotte, B.; Vayssiere, J. L. p53 can promote mitochondria- and caspase-independent apoptosis. Cell Death Differ. 2004, 11, 785-787. (Pubitemid 39023125)
32. Rudolf, E.; Rudolf, K.; Cervinka, M. Selenium activates p53 and p38 pathways and induces caspase-independent cell death in cervical cancer cells. Cell Biol. Toxicol. 2008, 24, 123-141. (Pubitemid 351311388)
33. Pizarro, J. G.; Folch, J.; Esparza, J. L.; Jordan, J.; Pallàs, M.; Camins, A. A molecular study of pathways involved in the inhibition of cell proliferation in neuroblastoma B65 cells by the GSK-3 inhibitors lithium and SB-415286. J. Cell. Mol. Med. 2008, Jun 20. [Epub ahead of print].
34. Liu, Y.; Templeton, D. M. Initiation of caspase-independent death in mouse mesangial cells by Cd2+: involvement of p38 kinase and CaMK-II. J. Cell. Physiol. 2008, 217, 307-318.
35. Kwon, C. H.; Yoon, C. S.; Kim, Y. K. Ciglitazone induces caspase-independent apoptosis via p38-dependent AIF nuclear translocation in renal epithelial cells. Toxicology 2008, 244, 13-24.
36. Miller, T. M.; Moulder, K. L.; Knudson, C. M.; Creedon, D. J.; Deshmukh, M.; Korsmeyer, S. J.; Johnson, Jr. E. M. Bax deletion further orders the cell death pathway in cerebellar granule cells and suggests a caspase-independent pathway to cell death. J. Cell. Biol. 1997, 139, 205-217.
37. Moubarak, R. S.; Yuste, V. J.; Artus, C.; Bouharrour, A.; Greer, P. A.; Menissier-de Murcia, J.; Susin, S. A. Sequential activation of poly(ADP ribose) polymerase 1, calpains, and Bax is essential in apoptosis-inducing factor-mediated programmed necrosis. Mol. Cell. Biol. 2007, 27, 4844-4862.
38. Susin, S. A.; Lorenzo, H. K.; Zamzami, N.; Marzo, I.; Snow, B. E.; Brothers, G. M. Molecular characterization of mitochondrial apoptosis inducing factor. Nature 1999, 397, 441-446. (Pubitemid 29078912)
39. Daugas, E.; Susin, S. A.; Zamzami, N.; Ferri, K. F.; Irinopoulou, T.; Larochette, N.; Prévost, M. C.; Leber, B.; Andrews, D.; Penninger, J.; Kroemer, G. Mitochondrio-nuclear translocation of AIF in apoptosis and necrosis. FASEB J. 2000, 14, 729-739. (Pubitemid 30198571)
40. Wang, X.; Yang, C.; Chai, J.; Shi, Y.; Xue, D. Mechanisms of AIF-mediated apoptotic degradation in Canorhabditis elegans. Science 2002, 298, 1587-1592. (Pubitemid 35387191)
41. Loeffler, M.; Daugas, E.; Susin, S. A.; Zamzami, N.; Metivier, D.; Nieminen, A. L.; Brothers, G.; Penninger, J. M.; Kroemer, G. Dominant cell death induction by extramitochondrially targeted apoptosis inducing factor. FASEB J. 2001, 15, 758-767. (Pubitemid 32245994)
42. Yu, S. W.; Baek, S. H.; Brennan, R. T.; Bradley, C. J.; Park, S. K.; Lee, Y. S.; Jun, E. J.; Lookingland, K. J.; Kim, E. K.; Lee, H.; Goudreau, J. L.; Kim, S. W. Mediation of poly(ADP-ribose) polymerase-1-dependent cell death by apoptosis-inducing factor. Science 2002, 297, 259-263. (Pubitemid 34761289)
43. Lorenzo, H. K.; Susin, S. A.; Penninger, J.; Kroemer, G. Apoptosis inducing factor (AIF): a phylogenetically old, caspase independent effector of cell death. Cell Death Differ. 1999, 6, 516-524. (Pubitemid 29292107)
44. Joseph, B.; Marchetti, P.; Formstecher, P.; Kromer, G.; Lewenshohn, R.; Zhivotovsky, B. Mitochondrial dysfunction is an essential step for killing of non-small cell lung carcinomas resistant to conventional treatment. Oncogene 2002, 21, 65-77. (Pubitemid 34076379)
45. Arnoult, D.; Parone, P.; Marinou, J. C.; Antonsson, B.; Estaquier, J.; Ameisen, J. C. Mitochondrial release of apoptosis-inducing factor occurs downstream of cytochrome c release in response to several proapoptotic stimuli. J. Cell. Biol. 2002, 159, 923-929.
46. Arnoult, D.; Gaume, B.; Karbowski, M.; Sharpe, J. C.; Cecconi, F.; Youle, R. J. Mitochondrial release of AIF and EndoG requires caspase activation downstream of Bax / Bak mediated permeabilization. EMBO J. 2003, 22, 4385-4399.
47. Stambolsky, P.; Weisz, L.; Shats, I.; Klein, Y.; Goldfinger, N.; Oren, M.; Rotter, V. Regulation of AIF expression by p53. Cell Death Differ. 2006, 13, 2140-2149.
48. Nylandsted, J.; Gyrd-Hansen, M.; Danielewicz, A.; Fehrenbacher, N.; Lademann, U.; Høyer-Hansen, M.; Weber, E.; Multhoff, G.; Rohde, M.; Jäättelä, M. Heat shock protein 70 promotes cell survival by inhibiting lysosomal membrane permeabilization. J. Exp. Med. 2004, 200, 425-435. (Pubitemid 39121900)
49. Kook, S. H.; Son, Y. O.; Chung, S. W.; Lee, S. A.; Kim, J. G.; Jeon, Y. M.; Lee, J. C. Caspase-independent death of human osteosarcoma cells by flavonoids is driven by p53-mediated mitochondrial stress and nuclear translocation of AIF and endonuclease G. Apoptosis 2007, 12, 1289-1298.
50. Wang, M.; Zhang, L.; Han, X.; Yang, J.; Qian, J.; Hong, S., Samaniego, F., Romaguera, J., Yi, Q. Atiprimod inhibits the growth of mantle cell lymphoma in vitro and in vivo and induces apoptosis via activating the mitochondrial pathways. Blood 2007, 109, 5455-5462. (Pubitemid 46890569)
51. Wang, X. The expanding role of mitochondria in apoptosis. Genes Dev. 2001, 15, 2922-2933.
52. Wolf, B. B.; Green, D. R. Apoptosis: letting slip the dogs of war. Curr. Biol. 2002, 12, R177-R179.
53. Johnson, D. E. Non-caspase proteases in apoptosis. Leukemia 2000, 14, 1695-1703.
54. Turk, V.; Turk, G.; Guncar, G.; Turk, D.; Kos, J. Lysosomal cathepsins: structure, role in antigen processing and presentation, and cancer. Adv. Enzyme Regul. 2002, 42, 285-303. (Pubitemid 35033544)
55. Reiners, J. J. Jr.; Caruso, P.; Mathieu, P.; Chelladurai, B.; Yin, X. M.; Kessel, D. Release of cytochrome c and activation of procaspase-9 following lysosomal photodamage involves Bid cleavage. Cell Death Differ. 2002, 9, 934-944. (Pubitemid 35033432)
56. Bidère, N.; Lorenzo, H. K.; Carmona, S.; Laforge, M.; Harper, F.; Dumont, C.; Senik, A. Cathepsin D triggers Bax activation, resulting in selective apoptosis-inducing factor (AIF) relocation in T lymphocytes entering the early commitment phase to apoptosis. J. Biol. Chem. 2003, 278, 31401-31411. (Pubitemid 36994661)
57. Cirman, T.; Oresić, K.; Mazovec, G. D.; Turk, V.; Reed, J. C.; Myers, R. M.; Salvesen, G. S.; Turk, B. Selective disruption of lysosomes in HeLa cells triggers apoptosis mediated by cleavage of Bid by multiple papain-like lysosmal cathepsins. J. Biol. Chem. 2004, 279, 3578-3597. (Pubitemid 38140598)
58. Stoka, V.; Turk, B.; Schendel, S. L.; Kim, T. H.; Cirman, T.; Snipas, S. J.; Ellerby, L. M.; Bredesen, D.; Freeze, H.; Abrahamson, M.; Bromme, D.; Krajewski, S.; Reed, J. C.; Yin, X. M.; Turk, V., Salvesen, G. S. Lysosomal protease pathways to apoptosis. Cleavage of Bid, not pro-caspases is the most likely route. J. Biol. Chem. 2001, 276, 3149-3157. (Pubitemid 37411606)
59. Heibein, J. A. Granzyme B-mediated cytochrome c release is regulated by the Bcl-2 family members Bid and Bax. J. Exp. Med. 2000, 192, 1391-1402.
60. Roberts, L. R.; Kurosawa, H.; Bronk, S. F.; Fesmier, P. J.; Agellon, L. B.; Leung, W. Y.; Mao, F.; Gores, G. J. Cathepsin B contributes to bile salt-induced apoptosis of rat hepatocytes. Gastroenterology 1997, 113, 1714-1726. (Pubitemid 27461261)
61. Deiss, L. P.; Galinka, H.; Berissi, H.; Cohen, O.; Kimchi, A. Cathepsin D protease mediates programmed cell death induced by interferon-gamma, Fas/APO-1 and TNF-alpha. EMBO J. 1996, 15, 3861-3870. (Pubitemid 26289796)
62. Susin, S. A.; Daugas, E.; Ravagnan, L.; Samejima, K.; Zamzami, N.; Loeffler, M.; Costantini, P.; Ferri, K. F.; Irinopoulou; T.; Prévost, M. C.; Brothers, G.; Mak, T. W.; Penninger, J.; Earnshaw, W. C.; Kroemer, G. Two distinct pathways leading to nuclear apoptosis. J. Exp. Med. 2000, 192, 571-580. (Pubitemid 30666258)
63. Vancompernolle, K.; Van Herreweghe, F.; Pynaert, G.; Van de Craen, M.; De Vos, K.; Totty, N.; Sterling, A.; Fiers, W.; Vandenabeele, P.; Grooten J. Actractyloside-induced release of cathepsin B, a protease with caspase processing activity. FEBS Lett. 1998, 438, 150-158. (Pubitemid 28529264)
64. Guroff, A. A neutral calcium-activated proteinase from the soluble fraction of the brain. J. Biol. Chem. 1964, 239, 149-155.
65. Choi, W. S.; Lee, E. H.; Chung, C. W.; Jung, Y. K.; Jin, B. K.; Kim, S. U.; Oh, T. H.; Saido, T. C.; Oh, Y. J. Cleavage of Bax is mediated by caspase-dependent or -independent calpain activation in dopaminergic neuronal cells: protective role of Bcl2. J. Neurochem. 2001, 77, 1531-1541.
66. Cao, X.; Deng, X.; May, W. S. Cleavage of Bax to p18Bax accelerates stress-induced apoptosis, and a cathepsin-like protease may rapidly degrade p18 Bax. Blood 2003, 102, 2605-2614.
67. Yamashima, T. Ca2+ dependent proteases in ischemic neuronal death: a conserved 'calpain-cathepsin cascade' from nematodes to primates. Cell Calcium 2004, 36, 285-293.
68. Mathiasen, I. S.; Sergeev, I. N.; Bratholm, L.; Elling, F.; Norman, A. W.; Jaatela, M. Calcium and calpain as key mediators of apoptosis like death induced by vitamin D compounds in breast cancer cells. J. Biol. Chem. 2002, 277, 30738-30745.
69. Narvaez, C. J.; Welsh, J. Role of mitochondria and caspases in vitamin D-mediated apoptosis of MCF7 breast cancer cells. J. Biol. Chem. 2001, 276, 9101-9107. (Pubitemid 37385490)
70. Egger, L.; Schneider, J.; Rheme, C.; Tapernoux, M.; Hacki, J.; Borner, C. Serine proteases mediate apoptosis-like cell death and phagocytosis under caspase-inhibiting conditions. Cell Death Differ. 2003, 10, 1188-1203. (Pubitemid 37258584)
71. O'Connell, A. R.; Stenson-Cox, C. A more serine way to die: Defining the characteristics of serine protease-mediated cell death cascades. Biochim. Biophys. Acta 2007, 1773, 1491-1499. (Pubitemid 47500175)
72. Suzuki, Y.; Imai, Y.; Nakayama, H.; Takahashi, K.; Takio, K.; Takahashi, R. A serine protease, htra2, is released from the mitochondria and interacts with xiap, inducing cell death. Mol. Cell 2001, 8, 613-621. (Pubitemid 32946938)
73. Wright, S. C.; Schellenberger, U.; Wang, H.; Wang, Y.; Kinder, D. H. Chemotherapeutic drug activation of the AP24 protease in apoptosis: requirement for caspase 3-like proteases. Biochem. Biophys. Res. Commun. 1998, 245, 797-803.
74. Suzuki, Y.; Takahashi-Niki, K.; Akagi, T.; Hashikawa, T.; Takahasi, R. Mitochondrial protease Omi/HtrA2 enhances caspase activation through multiple pathways. Cell Death Differ. 2004, 11, 208-216.
75. Friesen, C.; Fulda, S.; Debatin, K. M. Cytotoxic drugs and the CD95 pathway. Leukemia 1999, 13, 1854-1858.
76. Green, D. R. Apoptotic pathways: paper wraps stone blunts scissors. Cell 2000, 102, 1-4.
77. Reed, J. C. Apoptosis regulating proteins as targets for drug discovery. Trends Mol. Med. 2001, 7, 314-319. (Pubitemid 32606571)
78. Blagosklonny, M. V. Prospective strategies to enforce selectively cell death in cancer cells. Oncogene 2004, 23, 2967-2975. (Pubitemid 38638856)
79. Hu, W.; Kavanagh, J. J. Anticancer therapy targeting the apoptotic pathway. Lancet Oncol. 2003, 4, 721-729. (Pubitemid 37527207)
80. Kaufmann, S. H.; Vaux, D. L. Alterations in the apoptotic machinery and their potential role in anticancer drug resistance. Oncogene 2003, 22, 7414-7430. (Pubitemid 37487167)
81. Okun, I.; Balakin, K. V.; Tkachenko, S. E.; Ivachtchenko, A. V. Caspase activity modulators as anticancer agents. Anticancer Agents Med. Chem. 2008, 8, 322-341.
82. Hotte, S. J.; Hirte, H. W.; Chen, E. X.; Siu, L. L.; Le, L. H.; Corey, A.; Iacobucci, A.; MacLean, M.; Lo, L.; Fox, N. L.; Oza, A. M. A phase I study of mapatumumab (fully human monoclonal antibody to TRAIL-R1) in patients with advanced solid malignancies. Clin. Cancer Res. 2008, 14, 3450-3455.
83. Moreira, J. N.; Santos, A.; Simões, S. Bcl-2-targeted antisense therapy (Oblimersen sodium): towards clinical reality. Rev. Recent Clin. Trials 2006, 1, 217-235.
84. Kozuch, P. S.; Rocha-Lima, C. M.; Dragovich, T.; Hochster, H.; O'Neil, B. H.; Atiq, O. T.; Pipas, J. M.; Ryan, D. P.; Lenz, H. J. Bortezomib with or without irinotecan in relapsed or refractory colorectal cancer: results from a randomized phase II study. J. Clin. Oncol. 2008, 26, 2320-2326.
85. Lowe, S. W.; Ruley, H. E.; Jacks, T.; Housman, D. E. P53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell 1993, 74, 957-967. (Pubitemid 23289454)
86. Ashkenazi, A.; Dixit, V. M. Death receptors: signalling and modulation. Science 1998, 281, 1309-1312.
87. Roy, N.; Deveraux, Q. L.; Takahashi, R.; Salvesen, G. S.; Reed, J. C. The c-IAP-1 and c-IAP-2 proteins are direct inhibitors of specific caspases. EMBO J. 1998, 17, 6124-6134.
88. Mathiasen, I. S.; Jaatela, M. Triggering caspase-independent cell death to combat cancer. Trends Mol. Med. 2002, 8, 212-220. (Pubitemid 34493638)
89. Lockshin, R. A.; Zakeri, Z. Caspase-independent cell death? Oncogene 2004, 23, 2766-2773. (Pubitemid 38638840)
90. Brown, J. M.; Wouters, B. G. Apoptosis: mediator or mode of cell killing by anticancer agents? Drug Resist. Update 2001, 4, 135-136.
91. Bruynzeel, A. M.; Abou El Hassan, M. A.; Torun, E.; Bast, A.; van der Vijgh, W. J.; Kruyt, F. A. Caspase-dependent and -independent suppression of apoptosis by monoHER in Doxorubicin treated cells. Br. J. Cancer 2007, 96, 450-456. (Pubitemid 46215216)
92. Roberts, L. R.; Adjei, P. N.; Gores, G. J. Cathepsins as effector proteases in hepatocyte apoptosis. Cell Biochem. Biophys. 1999, 30, 71-88.
93. Ahn, H. J.; Kim, Y. S.; Kim, J. U.; Han, S. M.; Shin, J. W.; Yang, H. O. Mechanism of taxol induced apoptosis in human SKOV3 ovarian carcinoma cells. J. Cell. Biochem. 2004, 91, 1043-1052.
94. Kim, R. Recent advances in understanding the cell death pathways activated by anticancer therapy. Cancer 2005, 103, 1551-1560. (Pubitemid 40490015)
95. Zhang, W.; Zhang, C.; Narayani, N.; Du, C.; Balaji, K. C. Nuclear translocation of apoptosis inducing factor is associated with cisplatin induced apoptosis in LNCaP prostate cancer cells. Cancer Lett. 2007, 255, 127-134.
96. Rugo, H.; Shtivelman, E.; Perez, A.; Vogel, C.; Franco, S.; Tan Chiu, E.; Melisko, M.; Tagliaferri, M.; Cohen, I.; Shoemaker, M.; Tran, Z.; Tripathy, D. Phase I trial and antitumor effects of BZL101 for patients with advanced breast cancer. Breast Cancer Res. Treat. 2007, 105, 17-28. (Pubitemid 47282746)
97. Fong, S.; Shoemaker, M.; Cadaoas, J.; Lo, A.; Liao, W.; Tagliaferri, M.; Cohen, I.; Shtivelman, E. Molecular mechanisms underlying selective cytotoxic activity of BZL101, an extract of Scutellaria barbata, towards breast cancer cells. Cancer Biol. Ther. 2008, 7, 577-586. (Pubitemid 351847034)
98. Shapiro, G. I. Cyclin dependent kinase pathways as targets for cancer treatment. J. Clin. Oncol. 2006, 24, 1770-1783. (Pubitemid 46628473)
99. Maddika, S.; Ande, S. R.; Panigrahi, S.; Paranjothy, T.; Weglarczyk, K.; Zuse, A.; Eshraghi, M.; Manda, K. D.; Wiechec, E.; Los, M. Cell survival, cell death and cell cycle pathways are interconnected: implications for cancer therapy. Drug Resis. Updat. 2007, 10, 13-19. (Pubitemid 46636381)
100. Newcomb, E. W.; Tamasdan, C.; Entzminger, Y.; Alonso, J.; Friedlander, D.; Crisan, D.; Miller, D. C.; Zagzag, D. Flavopiridol induces mitochondrial-mediated apoptosis in murine glioma GL261 cells via release of cytochrome c and apoptosis inducing factor. Cell Cycle 2003, 2, 243-250.
101. Alonso, M.; Tamasdan, C.; Miller, D. C.; Newcomb, E. W. Flavopiridol induces apoptosis in glioma cell lines independent of retinoblastoma and p53 tumor suppressor pathway alterations by a caspase-independent pathway. Mol. Cancer Ther. 2003, 2, 139-150.
102. Shaffer, S. A.; Baker-Lee, C.; Kennedy, J.; Lai, M. S.; de Vries, P.; Buhler, K.; Singer, J. W. In vitro and in vivo metabolism of paclitaxel poliglumex: identification of metabolites and active proteases. Cancer Chemother. Pharmacol. 2007, 59, 537-540.
103. Albain, K. S.; Belani, C. P.; Bonomi, P.; O'Byre, K. J.; Schiller, J. H.; Socinski, M. PIONEER: a phase III randomized trial of paclitaxel poliglumex versus paclitaxel in chemotherapy-naive women with advanced-stage non small-cell lung cancer and performance status of 2. Clin. Lung Cancer 2006, 7, 417-419.
104. Parreño, M.; Casanova, I.; Céspedes, M. V.; Vaqué. J. P.; Pavón, M. A.; Leon, J.; Mangues, R. Bobel-24 and derivatives induce caspase-independent death in pancreatic cancer regardless of apoptotic resistance. Cancer Res. 2008, 68, 6313-6323.
105. Zhou, J.; Zhang, X. Q.; Ashoori, F.; McConkey, D. J.; Knowles, M. A.; Dong, L.; Benedict, W. F. Early RB94-produced cytotoxicity in cancer cells is independent of caspase activation or 50 kb DNA fragmentation. Cancer Gene Ther. 2009, 16, 13-19.
106. Gallego, M. A.; Joseph, B., Hemstrom, T. H.; Tamiji, S.; Mortier, L.; Kroemer, G.; Formstecher, P.; Zhivotovsky, B.; Marchetti, P. Apoptosis inducing factor determines the chemoresistance of non-small-lung carcinomas. Oncogene 2004, 23, 6282-6291. (Pubitemid 39215298)
107. Park, M. T.; Kim, M. J.; Kang, Y. H.; Choi, S. Y.; Lee, J. H.; Choi, J. A.; Kang, C. M.; Cho, C. K.; Kang, S.; Bae, S.; Lee, Y. S.; Chung, H. Y.; Lee, S. J. Phytosphingosine in combination with ionizing radiation enhances apoptotic cell death in radiation-resistant cancer cells through ROS-dependent and -independent AIF release. Blood 2005, 105, 1724-1733.
108. Schmitt, E.; Parcellier, A.; Gurbuxani, S.; Cande, C.; Hammann, A.; Morales, M. C.; Hunt, C. R.; Dix, D. J.; Kroemer, R. T.; Giordanetto, F.; Jäättelä, M.; Penninger, J. M.; Pance, A.; Kroemer, G.; Garrido, C. Chemosensitization by a non-apoptogenic heat shock protein 70-binding apoptosis-inducing factor mutant. Cancer Res. 2003, 63, 8233-8240. (Pubitemid 37549473)
109. Cande, C.; Cecconi, F.; Dessen, P.; Kroemer, G. Apoptosis-inducing factor (AIF): key to the conserved caspase-independent pathways of cell death? J. Cell Science 2002, 115, 4727-12734 (Pubitemid 36054627)
110. Porter, A. G.; Urbano, A. G. L. Does apoptosis-inducing factor (AIF) have both life and death functions in cells? BioEssays 2006, 28, 834-843.
111. Modjtahedi, N.; Giordanetto, F.; Madeo, F.; Kroemer, G. Apoptosis-inducing factor: vital and lethal. Trends Cell. Biol. 2006, 16, 264-272.
112. Candé, C.; Cohen, I.; Daugas, E.; Ravagnan, L.; Larochette, N.; Zamzami, N.; Kroemer, G. Apoptosis-inducing factor (AIF): a novel caspase-independent death effector released from mitochondria. Biochimie 2002, 84, 215-222. (Pubitemid 34936520)
113. Galluzzi, L.; Larochette, N.; Zamzami, N.; Kroemer, G. Mitochondria as therapeutic targets for cancer chemotherapy. Oncogene 2006, 25, 4812-4830. (Pubitemid 44192089)